The American Association for Cancer Research (AACR), a scientific society of over 17,000 laboratory and clinical cancer researchers, was founded in 1907 to facilitate communication and dissemination of knowledge among scientists and others dedicated to the cancer problem; to foster research in cancer and related biomedical sciences; to encourage presentation and discussion of new and important observations in the field; to foster public education, science education, and training; and to advance the understanding of cancer etiology, prevention, diagnosis, and treatment throughout the world.
Students in the ECSU labs are working on the role of tyrosine kinase inhibitors and other novel therapeutic agents on treatment of the brain cancer Astrocytoma. Visiting the AACR 2002 annual meeting at San Francisco, CA allowed them to experience and learn about the current progress in cancer therapy, diagnosis and epidemiology. For a brief description of the meeting and coverage of the major events go to AACR 93rd Annual Meeting Report.